GREENLAND MINES LTD (GRML) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $5.00; Common Stock, Value, IssuedUSD $15.88K; Additional Paid in CapitalUSD $96.54M; Retained Earnings (Accumulated Deficit)USD $-38.66M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $5.00; Common Stock, Value, IssuedUSD $12.12K; Additional Paid in CapitalUSD $86.43M; Retained Earnings (Accumulated Deficit)USD $-34.97M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $7.25K; Additional Paid in CapitalUSD $30.05M; Retained Earnings (Accumulated Deficit)USD $-21.11M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $7.03K; Additional Paid in CapitalUSD $29.71M; Retained Earnings (Accumulated Deficit)USD $-19.79M.
GREENLAND MINES LTD Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital, Common Stock USD | Common Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Partners' Capital Account, Units, Sold in Public Offering shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00 | $15.88K | $96.54M | $-38.66M | $57.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $5.00 | $12.12K | $86.43M | $-34.97M | $51.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $7.25K | $30.05M | $-21.11M | $9.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $7.03K | $29.71M | $-19.79M | $9.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $5.27K | $27.54M | $-16.89M | $10.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-09 | $500.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.85K | $13.43M | $-12.80M | $638.71K | 3 month · $495.50K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $2.71K | $11.75M | $-10.56M | $1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-15 | (m) | $1.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $1.99K | $9.65M | $-8.50M | $1.46M | (m) | (m) | 3 month · $8.52K | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.57K | (m) | $-5.54M | $-1.55M | (m) | (m) | (m) | $3.68M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $340.00 | (m) | $-7.73M | $360.01K | 3 month · $287.25K | 3 month · $1.91K | 3 month · $213.28K | (m) | (m) | (m) | (m) | 3 month · 11.50M |
| 2023-12-31 | (m) | $1.51K | $4.49M | $-3.92M | $-442.70K | (m) | (m) | (m) | $4.49M | (m) | (m) | (m) | 12 month · 11.50M |
| 2023-09-30 | (m) | $340.00 | (m) | $-6.44M | $698.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 11.50M |
| 2023-06-30 | (m) | $340.00 | (m) | $-6.05M | $-6.05M | (m) | (m) | (m) | (m) | $60.00M | (m) | (m) | 6 month · 11.50M |
| 2023-03-31 | (m) | $340.00 | (m) | $-4.88M | $-4.88M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $631.70K | 3 month · 11.50M |
| 2022-12-31 | (m) | $340.00 | (m) | $-4.04M | $-4.04M | (m) | (m) | (m) | (m) | (m) | 12 month · $6.90M | 12 month · $587.72K | 12 month · 11.50M |
| 2022-09-30 | (m) | $340.00 | (m) | $-4.01M | $-4.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 11.50M |
| 2022-06-30 | (m) | $340.00 | (m) | $-4.28M | $-4.28M | (m) | (m) | (m) | (m) | (m) | 3 month · $6.90M | (m) | 6 month · 11.50M |
| 2022-03-31 | (m) | $287.00 | $24.71K | $-8.57K | $16.43K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 10.00M |
| 2021-12-31 | (m) | (m) | (m) | $-3.56K | $-3.56K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | $-3.53K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | $-3.51K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | $-3.51K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |